Correct the record on the WSJ Editorial Board’s misguided FTC attack

Last week, the Wall Street Journal Editorial Board published an overly broad and overreaching opinion piece castigating the Federal Trade Commission for its lawsuit against PBMs for driving up the costs of medicines.

We can’t let that argument go uncontested. Subscribers can help us respond and correct the record by leaving a comment at the bottom of the opinion piece here.